Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis-Reference-Cited by-同舟云学术

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis

Published:2013-01 Issue:1 Volume:14 Page:199-202
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Klein Katrin,Süsal Caner,Schäfer Sebastian M.,Becker Luis Eduardo,Beimler Jörg,Schwenger Vedat,Zeier Martin,Schemmer Peter,Macher-Goeppinger Stephan,Scherer Sabine,Opelz Gerhard,Morath Christian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference11 articles.

1. Desensitization in HLA-incompatible kidney recipients and survival;Montgomery;N Engl J Med,2011

2. Presensitization: the problem and its management;Jordan;Clin J Am Soc Nephrol,2006

3. Prevention of antibody-mediated kidney transplant rejection;Morath;Transpl Int,2012

4. Rituximab and intravenous immune globulin for desensitization during renal transplantation;Vo;N Engl J Med,2008

5. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients;Glotz;Transplantation,1993

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase therapy: exploring its clinical uses;Expert Opinion on Pharmacotherapy;2022-11-23

2. Therapeutic Apheresis in Renal Transplantation: Indications and Strategies;Urinary Tract Infection and Nephropathy - Insights into Potential Relationship;2022-02-02

3. Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption;Frontiers in Medicine;2021-12-17

4. Immune responses following tocilizumab therapy to desensitize HLA‐sensitized kidney transplant candidates;American Journal of Transplantation;2021-06-23

5. Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates;Transplantation Direct;2021-04-22